RHONNA LEE: Open Payments
NPI 1780878017 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,787 in 78 payments from 28 companies in 2025. Trend: 2023 $2,883 · 2024 $2,235 · 2025 $2,787
Food & beverage: $2,787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $495 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $247 |
| Novo Nordisk Inc | 5 | $214 |
| Abbott Laboratories | 2 | $182 |
| Lilly USA, LLC | 5 | $169 |
| Phathom Pharmaceuticals, Inc. | 3 | $168 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Dexcom, Inc. | 2 | $114 |
| Janssen Pharmaceuticals, Inc | 1 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
Products named: CAPLYTA, FREESTYLE LIBRE 3, VOQUEZNA, VRAYLAR, Wegovy, REXULTI, QULIPTA, COBENFY.
Industry payments across WA — which companies pay providers there.
